Galmed Pharmaceuticals Ltd (GLMD) — Strategic Asset Allocation Index
Galmed Pharmaceuticals Ltd (GLMD) has a Strategic Asset Allocation Index of 0.0% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $15.78 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Galmed Pharmaceuticals Ltd (GLMD) asset resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Galmed Pharmaceuticals Ltd Strategic Asset Allocation Index (2014–2025)
This chart shows how Galmed Pharmaceuticals Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $15.78 Million USD. See Galmed Pharmaceuticals Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Galmed Pharmaceuticals Ltd (2014–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Galmed Pharmaceuticals Ltd from 2014 to 2025, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Galmed Pharmaceuticals Ltd (GLMD) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.0% | $0.00 | $- | $0.00 | $15.78 Million | ▼ -13.0 pp |
| 2024 | 13.0% | $2.12 Million | $- | $2.12 Million | $16.33 Million | ▼ -10.5 pp |
| 2023 | 23.5% | $3.27 Million | $- | $3.27 Million | $13.88 Million | ▲ +9.8 pp |
| 2022 | 13.7% | $1.84 Million | $337.00K | $1.50 Million | $13.42 Million | ▲ +13.7 pp |
| 2021 | 0.0% | $0.00 | $- | $0.00 | $30.50 Million | ▼ -1.3 pp |
| 2020 | 1.3% | $570.00K | $570.00K | $- | $44.15 Million | ▲ +0.3 pp |
| 2019 | 1.0% | $709.00K | $709.00K | $- | $69.85 Million | ▲ +0.8 pp |
| 2018 | 0.2% | $194.00K | $194.00K | $- | $87.89 Million | ▼ -2.9 pp |
| 2017 | 3.1% | $491.00K | $491.00K | $- | $15.79 Million | ▼ -3.4 pp |
| 2016 | 6.5% | $718.00K | $718.00K | $- | $11.07 Million | ▲ +2.4 pp |
| 2015 | 4.1% | $883.00K | $883.00K | $- | $21.55 Million | ▲ +1.6 pp |
| 2014 | 2.5% | $774.00K | $774.00K | $- | $31.41 Million | — |